Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK

Atherosclerosis

Volumn 210, Issue 1, 2010, Pages 114-121

  Bao, Xiao Mei ^a   Wu, Chun Fang ^a   Lu, Guo Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Atorvastatin; Homocysteine; Nox4; P38MAPK; ROS

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ATORVASTATIN; DIPHENYLIODONIUM SALT; HOMOCYSTEINE; MEVALONIC ACID; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) METHYLARGININE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; TETRAZOLIUM;

APOPTOSIS; ARTICLE; CELL ISOLATION; CELL VIABILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STEM CELL; WESTERN BLOTTING;

APOPTOSIS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HEPTANOIC ACIDS; HOMOCYSTEINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEVALONIC ACID; NADPH OXIDASE; ONIUM COMPOUNDS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRROLES; REACTIVE OXYGEN SPECIES; STEM CELLS;

EID: 77952428705     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.11.032     Document Type: Article

References (27)

1. Bautista L.E., Arenas I.A., Peñuela A., et al. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol 2002, 55(9):882-972.
2. Weiss N., Keller C., Hoffmann U., et al. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med 2002, 7(3):227-239.
3. Vignini A., Nanetti L., Bacchetti T., et al. Modification induced by homocysteine and low-density lipoprotein on human aortic endothelial cells: an in vitro study. J Clin Endocrinol Metab 2004, 89(9):4558-4561.
4. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 2003, 348:593-600.
5. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerate reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, (105):3017-3024.
6. Zhu J., Wang X., Chen J., et al. Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia. Arch Med Res 2006, 37(4):484-489.
7. Chen J.Z., Zhu J.H., Wang X.X. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol 2004, 36(February (2)):233-239.
8. Tan H., Jiang X., Yang F., et al. Hyperhomocysteinemia inhibits post-injury reendothelialization in mice. Cardiovasc Res 2006, 69(1):253-262.
9. Alam M.M., Mohammad A.A., Shuaib U., et al. Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis. J Cereb Blood Flow Metab 2009, 29(1):157-165.
10. Noor R., Shuaib U., Wang C.X. High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis 2007, 192(1):92-99.
11. Zhu J.H., Chen J.Z., Wang X.X., et al. Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol 2006, 40(5):648-652.
12. Alvarez-Maqueda M., El Bekay R., Monteseirin J., et al. Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration. Atherosclerosis 2004, 172(2):229-238.
13. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 2005, 6(1):27-36.
14. Ungvari Z., Csiszar A., Edwards J.G., et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NADPH oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2003, 23(3):418-424.
15. Carluccio M.A., Ancora M.A., Massaro M., et al. Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. Am J Physiol Heart Circ Physiol 2007, 293(4):H2344-H2354.
16. Urbich C., Knau A., Fichtlscherer S., et al. FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J 2005, 19(June (8)):974-976.
17. Wassmann S., Laufs U., Müller K. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 2002, 22(2):300-305.
18. Goettsch C., Goettsch W., Muller G. Nox4 overexpression activates reactive oxygen species and p38 MAPK in human endothelial cells. Biochem Biophys Res Commun 2009, 380(2):355-360.
19. El-Remessy A.B., Tang Y., Zhu G. Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. Mol Vis 2008, 14:2190-2203.
20. Uruno A., Sugawara A., Kudo M. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase. Hypertens Res 2008, 31(11):2085-2096.
21. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
22. Ten Freyhaus H., Huntgeburth M., Wingler K. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 2006, 71(2):331-341.
23. Li L., Zhu D.L., Shen W.L., Gao P.J. Increased migration of vascular adventitial fibroblasts from spontaneously hypertensive rats. Hypertens Res 2006, 29(2):95-103.
24. Werner N., Wassmann S., Ahlers P., et al. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007, 102(6):565-571.
25. He T., PetersonTE, Holmuhamedov E.L., et al. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol 2004, 24(11):2021-2027.
26. Bid M.R., Spokes K.C., Shih S.C., et al. NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem 2007, 282(48):35373-35385.
27. Kuroda J., Nakagawa K., Yamasaki T., et al. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 2005, 10(12):1139-1151.